Alnylam Pharmaceuticals Market Sentiment

SPY777.11−0.01%QQQ757.96+0.03%BTC/USD83,208.98−2.73%DIA510.78−0.05%GLD376.71+0.22%TLT77.12−0.03%

Premium

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$224.41

0.470.21%

Last update: Oct 7, 4:42 PM

$224.41

0.470.21%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Alnylam Pharmaceuticals Market Sentiment - Benzinga

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.2% short float

Options Flow▲ 0.72 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

0.72

More calls — Bullish

182 calls · 131 puts

Avg Consensus PT

$418

+86.5%

Highest Price Target

$583

+159.8%

Citigroup

Lowest Price Target

$256

+14.1%

Wells Fargo

Short Interest

7.2%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	JP Morgan	Jessica Fye—	+64.4%	$375 → $369	Maintained	Overweight
Sep 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+102.8%	$455 → $455	Maintained	Buy
Sep 8, 2026	Jefferies	Faisal Khurshid—	+15.9%	$230 → $260	Maintained	Hold
Sep 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+102.8%	$455 → $455	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+41.7%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	+14.1%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+40.4%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+102.8%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+87.2%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+51.5%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+100.5%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+67.1%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+56.0%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+33.7%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+56.0%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+40.8%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+41.7%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+89.4%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+59.1%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+78.2%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+82.7%	$460 → $410	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+82.7%	$505 → $410	Maintained	Buy
Jul 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+116.1%	$470 → $485	Maintained	Buy
Jul 10, 2026	Morgan Stanley	Michael Ulz—	+78.2%	$370 → $400	Maintained	Equal-Weight
Jun 29, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+109.4%	$510 → $470	Maintained	Buy